Sign In
Buy ALNY
$297.69
+5.53 (+1.89%)
At Close: Jun 09, 2026
Gilead Drug Remdesivir’s Use Against Coronavirus Could Become Obsolete, Analyst Says
02:53pm, Tuesday, 02'nd Jun 2020
In study results published last week, the Gilead drug seemed to get patients off a ventilator sooner than existing treatments. But an analyst notes the anomaly that patients on the drug for 5 days did
Alnylam Pharmaceuticals : Announces Recipients of Second Annual Advocacy for Impact Grants Program | MarketScreener
12:06pm, Tuesday, 02'nd Jun 2020Alnylam Announces Recipients of Second Annual Advocacy for Impact Grants Program
12:00pm, Tuesday, 02'nd Jun 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that seven patient advocacy groups will receive supportive funding as part of the company’s secon
Regeneron Pharmaceuticals, Inc. (REGN) Regeneron Oncology Investor Event, ASCO 2020 Conference (Transcript)
03:02am, Tuesday, 02'nd Jun 2020
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Regeneron Oncology Investor Event, ASCO 2020 Conference Call June 01, 2020 04:30 PM ET Company Participants Justin
Fauci says his contact with Trump has 'dramatically decreased'
01:35am, Tuesday, 02'nd Jun 2020
Comments likely to raise fears he is being squeezed out of White House as coronavirus continues to ravage US
Coronavirus live news: Dr Fauci says he hasn't spoken to Trump in two weeks as Pakistanis told to 'live with virus'
12:40am, Tuesday, 02'nd Jun 2020
UK’s 14-day quarantine rules criticised as ‘ridiculous’; Global deaths near 375,000; Spain reports no new deaths for the first time since March. Follow the latest updates
Xconomy: Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact
05:36pm, Monday, 01'st Jun 2020
Four years after Regeneron Pharmaceuticals and Intellia Therapeutics began working together to research the use of CRISPR/Cas9 to treat liver diseases,
Anthony Fauci on Covid-19 reopenings, vaccines, and moving at 'warp speed'
12:34pm, Monday, 01'st Jun 2020
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will discuss full results from the ILLUMINATE-A Phase 3 study of lumasiran in a web
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that management will discuss full results from th
Why virus stocks are driving market volatility
04:00pm, Saturday, 30'th May 2020
The market’s erratic response to lukewarm medical research for COVID-19 treatment and vaccine candidates isn’t expected to slow down as investors pin their...
Alnylam's NDA Accepted, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:ALNY)
04:50am, Friday, 29'th May 2020
Alnylam's Lumasiran NDA has been accepted. Argenx reports positive data from Efgartigimod trial. Co-Diagnostics discusses its coronavirus test kit.
Johnson & Johnson Receives Positive CHMP Opinion for Janssen’s Investigational Preventive Ebola Vaccine Regimen
12:00am, Friday, 29'th May 2020
Johnson & Johnson today announced that its Janssen Pharmaceutical Companies received a positive opinion from the Committee for Medicinal Products
